Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells

Published:2012-10 Issue:1-2 Volume:132 Page:176-185
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Badia Eric,Docquier Aurélie,Busson Muriel,Lapierre Marion,Pujol Pascal,Balaguer Patrick,Cavailles Vincent

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference57 articles.

1. Cancer statistics, 2009;Jemal;CA: A Cancer Journal for Clinicians,2009

2. Cancer statistics, 2012;Siegel;CA: A Cancer Journal for Clinicians,2012

3. Molecular/Genetic therapies in ovarian cancer: future opportunities and challenges;Ziebarth;Clinical Obstetrics and Gynecology,2012

4. Primary ovarian cancer chemotherapy: current standards of care;McGuire;British Journal of Cancer,2003

5. Major clinical research advances in gynecologic cancer in 2011;Suh;Journal of Gynecologic Oncology,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics;Frontiers in Oncology;2024-07-15

2. Dual Fulvestrant-Trametinib Therapy in Recurrent Low-Grade Serous Ovarian Cancer;The Oncologist;2020-05-18

3. Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challenges;Molecular and Cellular Endocrinology;2015-12

4. Effect of tamoxifen and fulvestrant long-term treatments on ROS production and (pro/anti)-oxidant enzymes mRNA levels in a MCF-7-derived breast cancer cell line;Breast Cancer;2015-07-21

5. Pharmacodynamic study of 131I-labeled CA215 antibody on an animal model of estrogen-resistant OC-3-VGH ovarian cancer;Experimental and Therapeutic Medicine;2015-05-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3